SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech informs about board meeting

15 Apr 2026 Evaluate

Windlas Biotech has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2026, inter-alia, to consider and approve the proposal for buyback of its fully paid-up equity shares of the company and the matters necessary and incidental thereto, in accordance with the applicable provisions of the Companies Act, 2013, including rules framed thereunder, the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended, and other applicable laws.

The above information is a part of company’s filings submitted to BSE.


Windlas Biotech Share Price

871.75 5.60 (0.65%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×